Clinical trial
Effects of AFQ056 and Nicotine in Reducing Cigarette Smoking
NCT00414752 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00414752 |
|---|---|
| Title | Effects of AFQ056 and Nicotine in Reducing Cigarette Smoking |
| Official title | A Randomized, Double Blind, Multiple Dose, Cross-Over, Placebo- and Active-Controlled Proof of Concept Study to Explore the Effects of AFQ056 and Nicotine (Active Comparator) on Craving and Withdrawal During Voluntary Smoking Abstinence in Healthy Smokers |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Smoking Abstinence |
| Intervention type | Drug |
| Interventions | AFQ065 |
| Enrollment | 36 |
| Start date | Sep 1, 2006 |
| First posted | Dec 22, 2006 |
| Last update posted | Jun 22, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: